AVBP
ArriVent BioPharma, Inc.
Company overview
- Market capitalization
- $1.44B
- Employees
- 77
- Latest publication
- 2026-09-29
About ArriVent BioPharma, Inc.
ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. The company's lead development candidate is firmonertinib, a tyrosine kinase inhibitor that is being evaluated in multiple clinical trials across a range of epidermal growth factor receptor mutations (EGFRm) in non-small cell lung cancer (NSCLC), including a Phase 3 clinical trial for treatment of patients with advanced or metastatic EGFRm NSCLC with exon 20 insertion mutations, as well as Phase 1b clinical trials to treat NSCLC patients with activating EGFRm, including P-loop and-alpha-c-helix compressing (PACC) mutations, and classical EGFRm NSCLC patients. It is also developing ARR-217, an antibody drug conjugate (ADC) for the treatment of gastrointestinal cancers; and ARR-002, ARR-421, and ARR-173 for solid tumors. The company has strategic collaborations with Aarvik Therapeutics Inc., Shanghai Allist Pharmaceuticals Co., Ltd., Beijing InnoCare Pharma Tech Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd., and Lepu Biopharma Co. Ltd. ArriVent BioPharma, Inc. was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 37,617,000USD | 32,175,000USD | 32,167,000USD | 27,720,000USD | 61,289,000USD | 20,163,000USD | 20,088,000USD | 21,778,000USD |
| Selling General Administrative | 8,494,000USD | 6,648,000USD | 6,149,000USD | 5,903,000USD | 5,483,000USD | 3,542,000USD | 4,144,000USD | 3,919,000USD |
| Total Operating Expenses | 46,111,000USD | 38,823,000USD | 38,316,000USD | 33,623,000USD | 66,772,000USD | 23,705,000USD | 24,232,000USD | 25,697,000USD |
| Operating Income | -46,111,000USD | -38,823,000USD | -38,316,000USD | -33,623,000USD | -66,772,000USD | -23,705,000USD | -24,232,000USD | -25,697,000USD |
| Interest Income | 2,791,000USD | 3,279,000USD | 3,338,000USD | 2,224,000USD | 2,385,000USD | 3,072,000USD | 3,668,000USD | 3,823,000USD |
| Net Interest Income | 2,791,000USD | 3,279,000USD | 3,338,000USD | 2,224,000USD | 2,385,000USD | 3,072,000USD | 3,668,000USD | 3,823,000USD |
| Income Before Tax | -43,320,000USD | -35,544,000USD | -34,978,000USD | -31,399,000USD | -64,387,000USD | -20,633,000USD | -20,564,000USD | -21,874,000USD |
| Net Income | -43,320,000USD | -35,544,000USD | -34,978,000USD | -31,399,000USD | -64,387,000USD | -20,633,000USD | -20,564,000USD | -21,874,000USD |
| Net Income From Continuing Ops | -43,320,000USD | -35,544,000USD | -34,978,000USD | -31,399,000USD | -64,387,000USD | -20,633,000USD | -20,564,000USD | -21,874,000USD |
| Ebitda | -46,111,000USD | -38,823,000USD | -34,978,000USD | -31,399,000USD | -66,772,000USD | -23,705,000USD | -24,232,000USD | -25,697,000USD |
| Total Other Income Expense Net | 2,791,000USD | 3,279,000USD | 3,338,000USD | 2,224,000USD | 2,385,000USD | 3,072,000USD | 3,668,000USD | 3,823,000USD |
| Ebit | — | — | — | -33,623,000USD | -66,772,000USD | -23,705,000USD | -24,232,000USD | -25,697,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — |
| Research Development | 153,351,000USD | 79,004,000USD | 64,884,000USD | 30,433,000USD | 6,434,000USD |
| Selling General Administrative | 24,183,000USD | 15,304,000USD | 9,706,000USD | 6,473,000USD | 3,016,000USD |
| Total Operating Expenses | 177,534,000USD | 94,308,000USD | 74,590,000USD | 36,906,000USD | 8,696,000USD |
| Operating Income | -177,534,000USD | -94,308,000USD | -74,590,000USD | -36,906,000USD | -8,696,000USD |
| Interest Income | 11,226,000USD | 13,820,000USD | 5,257,000USD | 0USD | — |
| Net Interest Income | 11,226,000USD | 13,820,000USD | 5,257,000USD | 0USD | — |
| Income Before Tax | -166,308,000USD | -80,488,000USD | -69,333,000USD | -36,906,000USD | -51,606,000USD |
| Net Income | -166,308,000USD | -80,488,000USD | -69,333,000USD | -36,906,000USD | -51,606,000USD |
| Net Income From Continuing Ops | -166,308,000USD | -80,488,000USD | -69,333,000USD | -36,906,000USD | — |
| Ebitda | -177,534,000USD | -80,488,000USD | -74,590,000USD | -36,906,000USD | -51,606,000USD |
| Total Other Income Expense Net | 11,226,000USD | 13,820,000USD | 5,257,000USD | — | -42,910,000USD |
| Income Tax Expense | — | -80,488,000USD | — | -36,906,000USD | -11,594,664USD |
| Ebit | — | -94,308,000USD | -74,590,000USD | -73,812,000USD | -63,200,664USD |
| Depreciation And Amortization | — | — | — | 36,906,000USD | 11,594,664USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 394,718,000USD | 333,169,000USD | 326,555,000USD | 269,506,000USD | 215,495,000USD | 274,942,000USD | 292,711,000USD | 308,855,000USD |
| Cash And Equivalents | 154,682,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 373,119,000USD | 312,821,000USD | 300,266,000USD | 235,687,000USD | 176,077,000USD | 218,863,000USD | 282,855,000USD | 298,669,000USD |
| Short Term Investments | 218,437,000USD | 267,281,000USD | 187,594,000USD | 122,922,000USD | 126,212,000USD | 144,570,000USD | — | — |
| Total Current Assets | 394,173,000USD | 332,897,000USD | 321,218,000USD | 250,149,000USD | 185,785,000USD | 226,979,000USD | 292,398,000USD | 308,511,000USD |
| Other Current Assets | 21,054,000USD | 20,076,000USD | 20,447,000USD | 13,957,000USD | 9,203,000USD | 7,616,000USD | 9,043,000USD | 9,092,000USD |
| Other Non Current Assets | 134,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 27,877,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 27,844,000USD | 25,945,000USD | 21,558,000USD | 19,636,000USD | 12,953,000USD | 17,274,000USD | 15,162,000USD | 12,098,000USD |
| Other Current Liabilities | 25,309,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 366,841,000USD | 307,224,000USD | 304,997,000USD | 249,870,000USD | 202,542,000USD | 257,654,000USD | 277,493,000USD | 296,659,000USD |
| Total Equity Including Noncontrolling Interest | 366,841,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 370,000USD | 13,000USD | 49,000USD | 85,000USD | 120,000USD | 154,000USD | 187,000USD | 219,000USD |
| Accounts Payable | 2,217,000USD | 5,934,000USD | 5,933,000USD | 4,060,000USD | 4,364,000USD | 3,782,000USD | 4,646,000USD | 3,812,000USD |
| Short Term Debt | 318,000USD | 14,000USD | 56,000USD | 98,000USD | 138,000USD | 162,000USD | 297,000USD | 152,000USD |
| Common Stock | 5,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -497,854,000USD | -404,641,000USD | -369,097,000USD | -334,119,000USD | -302,720,000USD | -238,333,000USD | -217,700,000USD | -197,136,000USD |
| Accumulated Other Comprehensive Income | -267,000USD | 14,000USD | 206,000USD | -18,000USD | -17,000USD | -211,000USD | — | 0USD |
| Total Liab | — | 25,945,000USD | 21,558,000USD | 19,636,000USD | 12,953,000USD | 17,288,000USD | 15,218,000USD | 12,196,000USD |
| Other Current Liab | — | 19,997,000USD | 15,569,000USD | 15,478,000USD | 8,451,000USD | 13,330,000USD | 10,219,000USD | 8,134,000USD |
| Capital Stock | — | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 3,000USD | 0USD | 3,000USD |
| Cash | — | 45,540,000USD | 112,672,000USD | 112,765,000USD | 49,865,000USD | 74,293,000USD | 282,855,000USD | 298,669,000USD |
| Net Debt | — | -45,526,000USD | -112,616,000USD | -112,667,000USD | -49,727,000USD | -74,117,000USD | -282,502,000USD | -298,419,000USD |
| Short Long Term Debt Total | — | 14,000USD | 56,000USD | 98,000USD | 138,000USD | 176,000USD | 353,000USD | 250,000USD |
| Long Term Investments | — | 0USD | 5,108,000USD | 18,793,000USD | 29,414,000USD | 47,683,000USD | — | — |
| Property Plant Equipment Gross | — | 13,000USD | 49,000USD | 85,000USD | 120,000USD | 154,000USD | 291,000USD | 219,000USD |
| Common Stock Shares Outstanding | — | 38,462,600shares | 41,912,905shares | 35,006,114shares | 33,899,000shares | 33,581,810shares | 33,581,810shares | 33,509,090shares |
| Non Current Assets Total | — | 272,000USD | 5,337,000USD | 19,357,000USD | 29,710,000USD | 47,963,000USD | 313,000USD | 344,000USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 14,000USD | 56,000USD | 98,000USD |
| Non Currrent Assets Other | — | 259,000USD | 180,000USD | 479,000USD | 176,000USD | 126,000USD | 126,000USD | 125,000USD |
| Net Working Capital | — | 306,952,000USD | 299,660,000USD | 230,513,000USD | 172,832,000USD | 209,705,000USD | 148,344,000USD | 296,413,000USD |
| Unclassified Equity | — | 711,843,000USD | 673,880,000USD | 583,999,000USD | 505,271,000USD | 496,192,000USD | 495,190,000USD | 493,789,000USD |
| Net Receivables | — | — | 505,000USD | 505,000USD | 505,000USD | 500,000USD | 500,000USD | 750,000USD |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Total Assets | 333,169,000USD | 274,942,000USD | 163,098,000USD | 182,833,000USD | 43,039,000USD |
| Other Current Assets | 20,076,000USD | 7,616,000USD | 9,579,000USD | 19,250,000USD | 5,672,000USD |
| Total Liab | 25,945,000USD | 17,288,000USD | 11,801,000USD | 8,371,000USD | 1,818,000USD |
| Total Stockholder Equity | 307,224,000USD | 257,654,000USD | 151,297,000USD | 174,462,000USD | 41,221,000USD |
| Other Current Liab | 19,997,000USD | 13,330,000USD | 6,952,000USD | 5,138,000USD | 1,525,000USD |
| Common Stock | 4,000USD | 3,000USD | — | 4,000USD | 4,000USD |
| Capital Stock | 4,000USD | 3,000USD | 0USD | 0USD | 89,865,000USD |
| Retained Earnings | -404,641,000USD | -238,333,000USD | -157,845,000USD | -88,512,000USD | -51,606,000USD |
| Cash | 45,540,000USD | 74,293,000USD | 150,389,000USD | 163,372,000USD | 37,280,000USD |
| Cash And Short Term Investments | 312,821,000USD | 218,863,000USD | 150,389,000USD | 163,372,000USD | 37,280,000USD |
| Total Current Assets | 332,897,000USD | 226,979,000USD | 159,968,000USD | 182,622,000USD | 42,952,000USD |
| Total Current Liabilities | 25,945,000USD | 17,274,000USD | 11,624,000USD | 8,360,000USD | 1,818,000USD |
| Net Debt | -45,526,000USD | -74,117,000USD | -150,072,000USD | -163,233,000USD | -37,280,000USD |
| Short Term Debt | 14,000USD | 162,000USD | 140,000USD | 128,000USD | — |
| Short Long Term Debt Total | 14,000USD | 176,000USD | 317,000USD | 139,000USD | — |
| Long Term Investments | 0USD | 47,683,000USD | 0USD | — | — |
| Short Term Investments | 267,281,000USD | 144,570,000USD | 0USD | — | — |
| Accounts Payable | 5,934,000USD | 3,782,000USD | 4,532,000USD | 3,094,000USD | 293,000USD |
| Property Plant Equipment Net | 13,000USD | 154,000USD | 291,000USD | 139,000USD | 0USD |
| Property Plant Equipment Gross | 13,000USD | 154,000USD | 291,000USD | 139,000USD | 0USD |
| Accumulated Other Comprehensive Income | 14,000USD | -211,000USD | — | -4,000USD | -2,000USD |
| Common Stock Shares Outstanding | 38,462,600shares | 31,469,328shares | 31,956,657shares | 33,493,750shares | 1,276,250shares |
| Non Current Assets Total | 272,000USD | 47,963,000USD | 3,130,000USD | 211,000USD | 87,000USD |
| Non Current Liabilities Total | 0USD | 14,000USD | 177,000USD | 11,000USD | 0USD |
| Non Currrent Assets Other | 259,000USD | 126,000USD | 2,839,000USD | 72,000USD | 87,000USD |
| Net Working Capital | 306,952,000USD | 209,705,000USD | 148,344,000USD | 174,262,000USD | 41,134,000USD |
| Unclassified Equity | 711,843,000USD | 496,192,000USD | 309,142,000USD | 262,974,000USD | 2,960,000USD |
| Net Receivables | — | 500,000USD | 761,000USD | 500,000USD | 250,000USD |
| Inventory | — | — | -240,000USD | — | — |
| Other Assets | — | — | — | 1USD | 1USD |
| Current Deferred Revenue | — | — | — | -1USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -43,320,000USD | -35,544,000USD | -34,978,000USD | -31,399,000USD | -64,387,000USD | -20,633,000USD | -20,564,000USD | -21,874,000USD |
| Depreciation | -559,000USD | -3,026,000USD | — | — | — | — | — | — |
| Stock Based Compensation | 5,485,000USD | 3,222,000USD | 3,716,000USD | 3,311,000USD | 2,271,000USD | 952,000USD | 866,000USD | 765,000USD |
| Other Non Cash Items | 4,926,000USD | — | — | — | — | 951,999USD | 835,000USD | -347,000USD |
| Change In Working Capital | -3,498,000USD | 4,690,000USD | -4,536,000USD | 1,964,000USD | -5,892,000USD | 3,529,000USD | 3,353,000USD | 2,022,000USD |
| Total Cash From Operating Activities | -41,892,000USD | -30,658,000USD | -35,798,000USD | -26,124,000USD | -68,008,000USD | -16,152,000USD | -16,345,000USD | -19,087,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -41,892,000USD | -30,658,000USD | -35,798,000USD | -26,124,000USD | -68,008,000USD | -16,152,000USD | -16,345,000USD | -19,087,000USD |
| Investments | 3,582,000USD | -71,199,000USD | -50,760,000USD | 13,910,000USD | 36,821,000USD | -192,465,000USD | 0USD | 0USD |
| Total Cashflows From Investing Activities | 3,582,000USD | -71,199,000USD | -50,760,000USD | 13,910,000USD | 36,821,000USD | -192,465,000USD | — | — |
| Total Cash From Financing Activities | 54,873,000USD | 34,725,000USD | 86,465,000USD | 75,114,000USD | 6,759,000USD | 55,000USD | 531,000USD | 363,000USD |
| Issuance Of Capital Stock | 54,724,000USD | 34,658,000USD | 86,116,000USD | 75,341,000USD | 6,516,000USD | 0USD | 0USD | 319,000USD |
| Change In Cash | 16,563,000USD | -67,132,000USD | -93,000USD | 62,900,000USD | -24,428,000USD | -208,562,000USD | -15,814,000USD | -18,724,000USD |
| Begin Period Cash Flow | 45,540,000USD | 112,672,000USD | 112,765,000USD | 49,865,000USD | 74,293,000USD | 282,855,000USD | 298,669,000USD | 317,393,000USD |
| End Period Cash Flow | 62,103,000USD | 45,540,000USD | 112,672,000USD | 112,765,000USD | 49,865,000USD | 74,293,000USD | 282,855,000USD | 298,669,000USD |
| Other Cashflows From Financing Activities | 54,873,000USD | -70,000USD | — | -227,000USD | 243,000USD | 55,000USD | 531,000USD | 44,000USD |
| Unclassified Operating Cash Flow | -4,926,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -54,724,000USD | — | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 1,699,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD |
|---|---|---|---|---|---|
| Net Income | -166,308,000USD | -80,488,000USD | -69,333,000USD | -36,906,000USD | -51,606,000USD |
| Depreciation | -3,026,000USD | — | — | — | — |
| Stock Based Compensation | 12,520,000USD | 3,208,000USD | 895,000USD | 424,000USD | 66,667USD |
| Other Non Cash Items | -3,026,000USD | — | 1,379USD | -2,376,000USD | 42,960,000USD |
| Change In Working Capital | -3,774,000USD | 7,068,000USD | 12,596,000USD | -7,149,000USD | -3,941,000USD |
| Total Cash From Operating Activities | -160,588,000USD | -70,212,000USD | -55,842,000USD | -43,631,000USD | -12,587,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -160,588,000USD | -70,212,000USD | -55,842,000USD | -43,631,000USD | -12,587,000USD |
| Investments | -71,228,000USD | -192,465,000USD | 0USD | 0USD | — |
| Total Cashflows From Investing Activities | -71,228,000USD | -192,465,000USD | — | — | -40,000,000USD |
| Total Cash From Financing Activities | 203,063,000USD | 186,581,000USD | 42,859,000USD | 169,723,000USD | 89,867,000USD |
| Issuance Of Capital Stock | 202,631,000USD | 185,950,000USD | 44,919,000USD | 169,708,000USD | — |
| Change In Cash | -28,753,000USD | -76,096,000USD | -12,983,000USD | 126,092,000USD | 37,280,000USD |
| Begin Period Cash Flow | 74,293,000USD | 150,389,000USD | 163,372,000USD | 37,280,000USD | — |
| End Period Cash Flow | 45,540,000USD | 74,293,000USD | 150,389,000USD | 163,372,000USD | 37,280,000USD |
| Other Cashflows From Financing Activities | -70,000USD | 631,000USD | 42,859,000USD | 169,721,000USD | 119,822,000USD |
| Unclassified Operating Cash Flow | 3,026,000USD | — | — | 2,376,000USD | — |
| Unclassified Financing Cash Flow | — | — | -44,919,000USD | -169,706,000USD | -29,955,000USD |
| Net Borrowings | — | — | — | 0USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | -40,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.